December 05, 2023CorporateTerumo Blood and Cell Technologies takes part in Connecting the DotsA new film series showcasing the pivotal role of medical technologies to improve healthcare
December 04, 2023FinancialNotice Concerning the Status of the Acquisition of Own Shares (PDF 112.21 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
Site Map Show — Site Map Hide — Site Map What’s new News Press Inquiries About Terumo Dear Stakeholders Who We Are Corporate Governance Compliance Regulations and Standards Procurement Activity At a Glance Terumo Group Identity Leadership Team History Terumo’s Purpose Terumo's Response to COVID-19 Business Overview TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division Life Care Solutions Division Pharmaceutical Solutions Division Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies) Sustainability Sustainability News Message from Top Management Sustainability at the Terumo Group Creating a Diverse and Inclusive Workplace Reducing Environmental Footprint Serving Our Communities Report Library GRI Standards Index Technology From Devices to Solutions Terumo’s strengths—the 3Ds The Solutions Terumo Aims for Basic Information Research and Development Production and Supply Intellectual Property Investors Management Policy Management Policy Top Management Message Business Risks Disclaimer IR Policy IR Library Financial Statements Presentations Terumo Reports IR Events IR Inquiries Financial Highlights Shareholders & Stock Shareholders Meeting Stock Information Shareholder Return Credit Ratings and Corporate Bond Analyst Coverage Articles of Incorporation Site Quote Terms and Conditions of Use Privacy Policy Social Media Policy
Top
Top